LEXARIA BIOSCIENCE CORP's ticker is LEXX and the CUSIP is 52886N406. A total of 17 filers reported holding LEXARIA BIOSCIENCE CORP in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $764,256 | +36.5% | 764,332 | -0.3% | 0.03% | +14.3% |
| Q2 2023 | $559,828 | -56.5% | 766,573 | +62.0% | 0.03% | -61.6% |
| Q1 2023 | $1,286,840 | +10.6% | 473,103 | 0.0% | 0.07% | -7.6% |
| Q4 2022 | $1,163,833 | +0.4% | 473,103 | 0.0% | 0.08% | -21.0% |
| Q3 2022 | $1,159,000 | +6.5% | 473,103 | +29.5% | 0.10% | +29.9% |
| Q2 2022 | $1,088,000 | +2.9% | 365,212 | 0.0% | 0.08% | -31.9% |
| Q1 2022 | $1,057,000 | -27.3% | 365,212 | +1.7% | 0.11% | -63.7% |
| Q4 2021 | $1,454,000 | -34.1% | 359,113 | +1.9% | 0.31% | -56.6% |
| Q3 2021 | $2,206,000 | -0.6% | 352,419 | +11.1% | 0.72% | +34.6% |
| Q2 2021 | $2,220,000 | +33.7% | 317,110 | +7.1% | 0.53% | +43.8% |
| Q1 2021 | $1,661,000 | – | 296,101 | – | 0.37% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Invenomic Capital Management LP | 764,332 | $764,256 | 0.03% |
| ARMISTICE CAPITAL, LLC | 889,272 | $889,183 | 0.01% |
| ROYAL BANK OF CANADA | 394 | $0 | 0.00% |
| VANGUARD GROUP INC | 33,329 | $33,326 | 0.00% |
| OSAIC HOLDINGS, INC. | 650 | $649 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,086 | $1,086 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 47,416 | $46,985 | 0.00% |
| 1832 Asset Management L.P. | 2,686 | $2,685 | 0.00% |
| TORONTO DOMINION BANK | 13 | $13 | 0.00% |